Boston University (BU) today announced it has been awarded a $2 million research grant from The Michael J. Fox Foundation for ...
ClearPoint Neuro, Inc. CLPT, a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, recently received EU MDR Certification for its ClearPoint ...
Boston Scientific (NYSE:BSX) announced today that it completed its previously announced acquisition of Nalu Medical.
Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.